REPORT ID 7138

Global Sustained Release Ocular Drug Delivery Systems Market ResearchReport 2019

Publish Date
2019
Pages
110
Format
Electronic (PDF)

In this report, the global Sustained Release Ocular Drug Delivery Systems market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sustained Release Ocular Drug Delivery Systems in these regions, from   2019 to 2025 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Sustained Release Ocular Drug Delivery Systems market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    pSivida
    Allergan
    Icon Bioscience
    Ocular Therapeutix
    Neurotech Pharmaceuticals
    Santen Pharmaceutical
    Aciont Inc.
    Envisia Therapeutics
    GrayBug
    Innocore Pharmaceuticals
    OHR Pharmaceuticals
    PolyActiva
    TheraKine
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Liposome
    Microcapsules/Nanocapsules
    Microspheres/Nanosptheres
    Implants
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Cataract
    Glaucoma
    Corneal Transplantation
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Sustained Release Ocular Drug Delivery Systems Market Research  Report 2019
1 Sustained Release Ocular Drug Delivery Systems Market Overview
    1.1 Product Overview and Scope of Sustained Release Ocular Drug Delivery Systems
    1.2 Sustained Release Ocular Drug Delivery Systems Segment by Type (Product Category)
        1.2.1 Global Sustained Release Ocular Drug Delivery Systems Production and CAGR (%) Comparison by Type (Product Category)( 2014-2024)
        1.2.2 Global Sustained Release Ocular Drug Delivery Systems Production Market Share by Type (Product Category)  in 2018
        1.2.3 Liposome
        1.2.4 Microcapsules/Nanocapsules
        1.2.5 Microspheres/Nanosptheres
        1.2.6 Implants
    1.3 Global Sustained Release Ocular Drug Delivery Systems Segment by Application
        1.3.1 Sustained Release Ocular Drug Delivery Systems Consumption (Sales) Comparison by Application ( 2014-2024)
        1.3.2 Cataract
        1.3.3 Glaucoma
        1.3.4 Corneal Transplantation
        1.3.5 Others
    1.4 Global Sustained Release Ocular Drug Delivery Systems Market by Region ( 2014-2024)
        1.4.1 Global Sustained Release Ocular Drug Delivery Systems Market Size (Value) and CAGR (%) Comparison by Region ( 2014-2024)
        1.4.2 North America Status and Prospect ( 2014-2024)
        1.4.3 Europe Status and Prospect ( 2014-2024)
        1.4.4 China Status and Prospect ( 2014-2024)
        1.4.5 Japan Status and Prospect ( 2014-2024)
        1.4.6 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.7 India Status and Prospect ( 2014-2024)
    1.5 Global Market Size (Value) of Sustained Release Ocular Drug Delivery Systems ( 2014-2024)
        1.5.1 Global Sustained Release Ocular Drug Delivery Systems Revenue Status and Outlook ( 2014-2024)
        1.5.2 Global Sustained Release Ocular Drug Delivery Systems Capacity, Production Status and Outlook ( 2014-2024)

2 Global Sustained Release Ocular Drug Delivery Systems Market Competition by Manufacturers
    2.1 Global Sustained Release Ocular Drug Delivery Systems Capacity, Production and Share by Manufacturers ( 2014-2019)
        2.1.1 Global Sustained Release Ocular Drug Delivery Systems Capacity and Share by Manufacturers ( 2014-2019)
        2.1.2 Global Sustained Release Ocular Drug Delivery Systems Production and Share by Manufacturers ( 2014-2019)
    2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Share by Manufacturers ( 2014-2019)
    2.3 Global Sustained Release Ocular Drug Delivery Systems Average Price by Manufacturers ( 2014-2019)
    2.4 Manufacturers Sustained Release Ocular Drug Delivery Systems Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Sustained Release Ocular Drug Delivery Systems Market Competitive Situation and Trends
        2.5.1 Sustained Release Ocular Drug Delivery Systems Market Concentration Rate
        2.5.2 Sustained Release Ocular Drug Delivery Systems Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue (Value) by Region ( 2014-2019)
    3.1 Global Sustained Release Ocular Drug Delivery Systems Capacity and Market Share by Region ( 2014-2019)
    3.2 Global Sustained Release Ocular Drug Delivery Systems Production and Market Share by Region ( 2014-2019)
    3.3 Global Sustained Release Ocular Drug Delivery Systems Revenue (Value) and Market Share by Region ( 2014-2019)
    3.4 Global Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.5 North America Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.6 Europe Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.7 China Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.8 Japan Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.9 Southeast Asia Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.10 India Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)

4 Global Sustained Release Ocular Drug Delivery Systems Supply (Production), Consumption, Export, Import by Region ( 2014-2019)
    4.1 Global Sustained Release Ocular Drug Delivery Systems Consumption by Region ( 2014-2019)
    4.2 North America Sustained Release Ocular Drug Delivery Systems Production, Consumption, Export, Import ( 2014-2019)
    4.3 Europe Sustained Release Ocular Drug Delivery Systems Production, Consumption, Export, Import ( 2014-2019)
    4.4 China Sustained Release Ocular Drug Delivery Systems Production, Consumption, Export, Import ( 2014-2019)
    4.5 Japan Sustained Release Ocular Drug Delivery Systems Production, Consumption, Export, Import ( 2014-2019)
    4.6 Southeast Asia Sustained Release Ocular Drug Delivery Systems Production, Consumption, Export, Import ( 2014-2019)
    4.7 India Sustained Release Ocular Drug Delivery Systems Production, Consumption, Export, Import ( 2014-2019)

5 Global Sustained Release Ocular Drug Delivery Systems Production, Revenue (Value), Price Trend by Type
    5.1 Global Sustained Release Ocular Drug Delivery Systems Production and Market Share by Type ( 2014-2019)
    5.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Type ( 2014-2019)
    5.3 Global Sustained Release Ocular Drug Delivery Systems Price by Type ( 2014-2019)
    5.4 Global Sustained Release Ocular Drug Delivery Systems Production Growth by Type ( 2014-2019)

6 Global Sustained Release Ocular Drug Delivery Systems Market Analysis by Application
    6.1 Global Sustained Release Ocular Drug Delivery Systems Consumption and Market Share by Application ( 2014-2019)
    6.2 Global Sustained Release Ocular Drug Delivery Systems Consumption Growth Rate by Application ( 2014-2019)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Sustained Release Ocular Drug Delivery Systems Manufacturers Profiles/Analysis
    7.1 pSivida
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.1.4 Main Business/Business Overview
    7.2 Allergan
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.2.4 Main Business/Business Overview
    7.3 Icon Bioscience
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.3.4 Main Business/Business Overview
    7.4 Ocular Therapeutix
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.4.4 Main Business/Business Overview
    7.5 Neurotech Pharmaceuticals
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.5.4 Main Business/Business Overview
    7.6 Santen Pharmaceutical
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.6.4 Main Business/Business Overview
    7.7 Aciont Inc.
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.7.4 Main Business/Business Overview
    7.8 Envisia Therapeutics
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.8.4 Main Business/Business Overview
    7.9 GrayBug
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.9.4 Main Business/Business Overview
    7.10 Innocore Pharmaceuticals
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.10.4 Main Business/Business Overview
    7.11 OHR Pharmaceuticals
    7.12 PolyActiva
    7.13 TheraKine

8 Sustained Release Ocular Drug Delivery Systems Manufacturing Cost Analysis
    8.1 Sustained Release Ocular Drug Delivery Systems Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Sustained Release Ocular Drug Delivery Systems Market Forecast ( 2019-2025)
    12.1 Global Sustained Release Ocular Drug Delivery Systems Capacity, Production, Revenue Forecast ( 2019-2025)
        12.1.1 Global Sustained Release Ocular Drug Delivery Systems Capacity, Production and Growth Rate Forecast ( 2019-2025)
        12.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate Forecast ( 2019-2025)
        12.1.3 Global Sustained Release Ocular Drug Delivery Systems Price and Trend Forecast ( 2019-2025)
    12.2 Global Sustained Release Ocular Drug Delivery Systems Production, Consumption , Import and Export Forecast by Region ( 2019-2025)
        12.2.1 North America Sustained Release Ocular Drug Delivery Systems Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.2 Europe Sustained Release Ocular Drug Delivery Systems Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.3 China Sustained Release Ocular Drug Delivery Systems Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.4 Japan Sustained Release Ocular Drug Delivery Systems Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.5 Southeast Asia Sustained Release Ocular Drug Delivery Systems Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.6 India Sustained Release Ocular Drug Delivery Systems Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
    12.3 Global Sustained Release Ocular Drug Delivery Systems Production, Revenue and Price Forecast by Type ( 2019-2025)
    12.4 Global Sustained Release Ocular Drug Delivery Systems Consumption Forecast by Application ( 2019-2025)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer